<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00854256</url>
  </required_header>
  <id_info>
    <org_study_id>iScience-022-CG</org_study_id>
    <nct_id>NCT00854256</nct_id>
  </id_info>
  <brief_title>Trabeculectomy Versus Canaloplasty to Treat Glaucoma</brief_title>
  <official_title>Comparison of Canaloplasty and Trabeculectomy in Patients With Open Angle Glaucoma and Inadequate Local Eye Pressure Lowering Therapy - a Prospective, Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cologne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>iScience Interventional Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Cologne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to investigate pressure lowering effect of two surgical methods
      canaloplasty and trabeculectomy in patients with open angle glaucoma, in which under local
      pressure lowering therapy the progression of the disease could not be stopped, and thus a
      pressure lowering surgical intervention is necessary. The risks in the postoperative course
      in Canaloplasty in the literature as lower than for the trabeculectomy with mitomycin-C.
      Conversely, large glaucoma centers questioning the effectiveness of permanent pressure
      lowering of canaloplasty. Precisely this question is investigated in the study.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2009</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Eye pressure</measure>
    <time_frame>Within 12 month after surgery</time_frame>
    <description>Eye pressure is measured after 1 month, 2 months, 3 months, 6 months, 9 months, and 12 months after surgery.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>Canaloplasty</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Trabeculectomy with mitomycin C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Canaloplasty</intervention_name>
    <description>Canaloplasty surgery</description>
    <arm_group_label>Canaloplasty</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Trabeculectomy with mitomycin C</intervention_name>
    <description>Trabeculectomy with mitomycin C surgery</description>
    <arm_group_label>Trabeculectomy with mitomycin C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with open angle glaucoma and excavation of 0.4 - 0.8

          -  60 eyes of 60 patients (30 patients for trabeculectomy, 30 patients for Canaloplasty)
             The ratio of female / male is not involved.

          -  Eye pressure under local therapy: 20mmHg and above (corrected with pachymetry table).

          -  Local drug therapy: at least 2 eye pressure lowering ingredients or absolute
             intolerance to preservatives or eye drops.

          -  general anesthesia possible.

          -  The operation must be signed by the surgeon as a state-of-the-art performed without
             complication to be evaluated. If the operation does not meet this criterion, the
             patient is excluded from the study.

        Exclusion Criteria:

          -  all patients are not included in the group of inclusion criteria, or:

          -  Phenprocoumon therapy.

          -  operation is not done state-of-the-art.

          -  after the surgery: additional eye pressure lowering surgery, cataract surgery,
             keratoplasty, laser surgery in the anterior eye segment (except suture lysis after
             trabeculectomy)

          -  Uveitis, or possible inflammation of the eye

          -  Previous eye pressure lowering operations or laser interventions

          -  Corneal Refractive Surgery (pseudophakia allowed)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Gerhard Welsandt, MD</last_name>
    <phone>+49-221-478-0</phone>
    <email>g.welsandt@uni-koeln.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre of Ophthalmology, University of Cologne</name>
      <address>
        <city>Cologne</city>
        <state>NRW</state>
        <zip>50924</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2009</study_first_submitted>
  <study_first_submitted_qc>March 2, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2009</study_first_posted>
  <last_update_submitted>April 12, 2013</last_update_submitted>
  <last_update_submitted_qc>April 12, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 15, 2013</last_update_posted>
  <responsible_party>
    <name_title>Gerhard Welsandt, MD</name_title>
    <organization>University of Cologne</organization>
  </responsible_party>
  <keyword>glaucoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitomycins</mesh_term>
    <mesh_term>Mitomycin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

